Among the characteristic gene generated from the model, loss of VIPR1 expression in HCC facilitated CAD phosphorylation and tumor progression, suggesting that the restoration of VIPR1 and treatment with the VIPR1 agonist may represent a promising approach for HCC treatment (32, 36). The gene discussed is VIPR1; the disease is hepatocellular carcinoma.